12 research outputs found
Two models of risk estimates (odd ratios) for frequencies of neuropsychiatric symptoms in the NPI between the VH+ and VH− AD groups.
<p>Two models of risk estimates (odd ratios) for frequencies of neuropsychiatric symptoms in the NPI between the VH+ and VH− AD groups.</p
Comparison of the subscale scores in the twelve-item NPI between the VH+ and VH− AD groups.
<p>AD, Alzheimer’s disease; VH, visual hallucination. * <i>p</i> < 0.05; ** <i>p</i> < 0.005.</p
Clinical manifestation of patients with Alzheimer’s disease presenting with or without visual hallucinations (VHs).
<p>Clinical manifestation of patients with Alzheimer’s disease presenting with or without visual hallucinations (VHs).</p
Comparison of composite score (severity x frequency) of each item in the NPI among the PDD, DLB and AD groups adjusted for gender and use of antipsychotics.
<p>Comparison of composite score (severity x frequency) of each item in the NPI among the PDD, DLB and AD groups adjusted for gender and use of antipsychotics.</p
Two models of risk estimates (odd ratios) for frequencies of neuropsychiatric symptoms in the NPI between the VH+ and VH− AD groups.
<p>Two models of risk estimates (odd ratios) for frequencies of neuropsychiatric symptoms in the NPI between the VH+ and VH− AD groups.</p
Multivariate risk estimates (ORs) for all patients with NPI ≥ 21 (N = 440, 50.3%) compared to those with NPI ≤ 20 (N = 435, 49.7%).
<p>Multivariate risk estimates (ORs) for all patients with NPI ≥ 21 (N = 440, 50.3%) compared to those with NPI ≤ 20 (N = 435, 49.7%).</p
Demographic and background characteristics of patients with Alzheimer’s disease (AD) with or without visual hallucinations (VHs).
<p>Demographic and background characteristics of patients with Alzheimer’s disease (AD) with or without visual hallucinations (VHs).</p
Comparison of demographic data among the PDD, DLB and AD groups.
<p>Comparison of demographic data among the PDD, DLB and AD groups.</p
Crude and multivariable risk estimates (odd ratios) for depressive symptoms between DLB and AD.
<p>Crude and multivariable risk estimates (odd ratios) for depressive symptoms between DLB and AD.</p
Frequencies of individual depressive symptoms in AD, probable DLB, possible DLB, and DLB participants.
<p>AD: Alzheimer’s disease; probable DLB: probable Dementia with Lewy bodies; possible DLB: possible Dementia with Lewy bodies; DLB: probable and possible Dementia with Lewy bodies. * p < 0.05; ** p < 0.005. Error bars represent 95% confidence intervals.</p